Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Netherlands Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20061
20071
20082
20093
20102
20114
20122
20132
20141
20162
20172
20181
20194
20201
20222
20232
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated8
Recruiting6
Active, not recruiting6
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
GlaxoSmithKline4
Eli Lilly and Company3
Amgen2
AstraZeneca2
Imperial College London2
Pfizer2
Sanofi2
Takeda2
United Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases45
Heart Diseases8
Myocardial Infarction8
Stroke8
Atherosclerosis7
Hypertension7
Vascular Diseases7
Acute Coronary Syndrome5
Aortic Valve Stenosis5
Coronary Artery Disease5

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.